A CrystEngComm one-day symposium on pharmaceutical polymorphism was held in London in November 2011. The purpose of RSC journal symposia is to bring together scientists in a stimulating and friendly environment that fosters collaborations between the researchers and the universities involved in the meetings. The CrystEngComm symposium featured a selection of lectures reflecting the academic and industrial breadth of the field of pharmaceutical polymorphism. Talks by internationally recognised researchers covered the following topics: solid form screening, selection and manufacturing; thermodynamics, phase diagrams, properties, characterization; structure prediction; and patents.
The symposium was supported by CrystEngComm, a journal at the forefront of the design and understanding of solid-state and crystalline materials, from RSC Publishing.
Venue and dates
The symposium took place on Friday 4th November at the Chemistry Centre at Burlington House, London, UK.
- Z. Jane Li, Boehringer Ingelheim, USA
- Graeme Day, University of Cambridge, UK
- Írn Almarsson, Alkermes Inc., USA
- Ann Newman, Seventh Street Development Group, IN, USA
- Ivo Rietveld, Universite Paris Descartes, France
- Jamshed Anwar, University of Bradford, UK
- Simon Black, Astra Zeneca, UK
- Avijit Kelkar, Dr Reddy's Laboratories (UK) Limited, UK
Cambridge Crystallographic Data Centre (CCDC) exhibited at the symposium.
PDF files require Adobe Acrobat Reader
More about CrystEngComm
CrystEngComm Homepage link
Read the latest blog posts from CrystEngComm
External links will open in a new browser window
Contact and Further Information
Dr Jamie Humphrey
Editor, Dalton Transactions
Royal Society of Chemistry, Thomas Graham House, Science Park, Milton Road, Cambridge, CB4 0WF
Tel: +44 (0) 1223 432139